Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Ovation Science (OVATF) Stock Price & Analysis

OVATF Stock Chart & Stats

$0.01$0.00(0.00%)
At close: 11:39 AM EDT
$0.025$0.03$0.035$0.0428 Jul4 Aug
Day’s Range
$0.04 - $0.04
52-Week Range
$0.01 - $0.08
Previous Close
$0.03
Volume
N/A
Average Volume (3M)
1,230
Market Cap
$825.24K
Enterprise Value
$855.55K
Total Cash (Recent Filing)
$13.22K
Total Debt (Recent Filing)
$292.14K
Price to Earnings (P/E)
―
Beta
0.82
Next Earnings
Nov 30, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Proprietary Transdermal Technology

A proprietary transdermal delivery approach can differentiate Ovation’s topical products from conventional formulations and provide a platform for multiple skin-related applications. If commercialization progresses, this technology-centered model may support repeat product development and longer-term competitive positioning.

Improved Cash-Burn Control

Materially lower cash burn indicates some cost containment and better operating discipline compared with earlier periods. Although cash generation remains negative, maintaining this improvement could extend financial runway, reduce funding pressure, and create more time for products to gain commercial traction.

Focused Topical Product Platform

A focused portfolio spanning personal care and skin health gives Ovation a defined commercial identity rather than an unrelated collection of activities. Concentrating development and marketing around topical products may help prioritize resources and build capabilities within a consistent product category.

Bears Say

Persistent Unprofitability

Persistent operating and net losses show that the business has not yet established a profitable operating model. Continued losses can restrict reinvestment, weaken financial resilience, and make future growth dependent on outside capital unless revenue and margins improve sustainably.

Negative Equity And Financing Risk

Negative equity is a significant balance-sheet weakness because liabilities exceed the recorded asset base and financial flexibility is limited. Combined with existing debt and ongoing losses, this increases recapitalization and dilution risk if the company needs funding to continue operations.

Negative Cash Generation

Consistently negative operating and free cash flow means the business does not currently fund itself through operations. Even with improved burn, ongoing cash deficits can require external financing, constrain investment in commercialization, and expose shareholders to funding or dilution pressure.

Ovation Science News

OVATF FAQ

What was Ovation Science’s price range in the past 12 months?
Ovation Science lowest stock price was $0.01 and its highest was $0.08 in the past 12 months.
What is Ovation Science’s market cap?
Ovation Science’s market cap is $825.24K.
When is Ovation Science’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Ovation Science’s earnings last quarter?
Ovation Science released its earnings results on Aug 11, 2026. The company reported -$0.003 earnings per share for the quarter.
Is Ovation Science overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Ovation Science pay dividends?
Ovation Science does not currently pay dividends.
What is Ovation Science’s EPS estimate?
Ovation Science’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ovation Science have?
Ovation Science has 38,441,680 shares outstanding.
What happened to Ovation Science’s price movement after its last earnings report?
Ovation Science reported an EPS of -$0.003 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Ovation Science?
Currently, no hedge funds are holding shares in OVATF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology